Antinociceptive effects of melatonin in a rat model of post-inflammatory visceral hyperalgesia: A centrally mediated process

Pain

Volumn 149, Issue 3, 2010, Pages 555-564

  Mickle, Aaron ^a   Sood, Manu ^a   Zhang, Zhihong ^a   Shahmohammadi, Golbon ^a   Sengupta, Jyoti N ^a   Miranda, Adrian ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Colorectal distension; Melatonin; MT receptors; Visceral hyperalgesia

Indexed keywords

LUZINDOLE; MELATONIN; NALTREXONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; COLITIS; COLON DILATATION; CONTROLLED STUDY; DRUG MECHANISM; ELECTROPHYSIOLOGY; HYPERALGESIA; LUMBOSACRAL SPINE; MALE; NONHUMAN; PELVIC NERVE; PRIORITY JOURNAL; RAT; SPINAL CORD NERVE CELL; VASOMOTOR REFLEX; VISCERA;

ANALGESICS; ANIMALS; COLITIS; DISEASE MODELS, ANIMAL; HYPERALGESIA; INFLAMMATION; MALE; MELATONIN; NARCOTIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MELATONIN; TRYPTAMINES; VISCERAL AFFERENTS;

EID: 77952109906     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2010.03.030     Document Type: Article

References (30)

1. Ambriz-Tututi M., and Granados-Soto V. Oral and spinal melatonin reduces tactile allodynia in rats via activation of MT2 and opioid receptors. Pain 132 (2007) 273-280
2. Arreola-Espino R., Urquiza-Marin H., Ambriz-Tututi M., Araiza-Saldana C.I., Caram-Salas N.L., Rocha-Gonzalez H.I., Mixcoatl-Zecuatl T., and Granados-Soto V. Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats. Eur J Pharmacol 577 (2007) 203-210
3. Ayar A., Martin D.J., Ozcan M., and Kelestimur H. Melatonin inhibits high voltage activated calcium currents in cultured rat dorsal root ganglion neurones. Neurosci Lett 313 (2001) 73-77
4. Bubenik G.A. Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 47 (2002) 2336-2348
5. Cuzzocrea S., Costantino G., Mazzon E., and Caputi A.P. Regulation of prostaglandin production in carrageenan-induced pleurisy by melatonin. J Pineal Res 27 (1999) 9-14
6. Drago F., Macauda S., and Salehi S. Small doses of melatonin increase intestinal motility in rats. Dig Dis Sci 47 (2002) 1969-1974
7. El-Shenawy S.M., Abdel-Salam O.M., Baiuomy A.R., El-Batran S., and Arbid M.S. Studies on the anti-inflammatory and antinociceptive effects of melatonin in the rat. Pharmacol Res 46 (2002) 235-243
8. Golombek D.A., Escolar E., Burin L.J., De Brito Sanchez M.G., and Cardinali D.P. Time-dependent melatonin analgesia in mice: inhibition by opiate or benzodiazepine antagonism. Eur J Pharmacol 194 (1991) 25-30
9. Huether G., Poeggeler B., Adler L., and Ruther E. Effects of indirectly acting 5-HT receptor agonists on circulating melatonin levels in rats. Eur J Pharmacol 238 (1993) 249-254
10. Lahiri S., Singh P., Singh S., Rasheed N., Palit G., and Pant K.K. Melatonin protects against experimental reflux esophagitis. J Pineal Res 46 (2009) 207-213
11. Laurido C., Pelissie T., Soto-Moyano R., Valladares L., Flores F., and Hernandez A. Effect of melatonin on rat spinal cord nociceptive transmission. Neuroreport 13 (2002) 89-91
12. Lu W.Z., Gwee K.A., Moochhalla S., and Ho K.Y. Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study. Aliment Pharmacol Ther 22 (2005) 927-934
13. Mantovani M., Kaster M.P., Pertile R., Calixto J.B., Rodrigues A.L., and Santos A.R. Mechanisms involved in the antinociception caused by melatonin in mice. J Pineal Res 41 (2006) 382-389
14. Mantovani M., Pertile R., Calixto J.B., Santos A.R., and Rodrigues A.L. Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-d-aspartate receptors and the L-arginine-nitric oxide pathway. Neurosci Lett 343 (2003) 1-4
15. Miranda A., Peles S., Shaker R., Rudolph C., and Sengupta J.N. Neonatal nociceptive somatic stimulation differentially modifies the activity of spinal neurons in rats and results in altered somatic and visceral sensation. J Physiol 572 (2006) 775-787
16. Noseda R., Hernandez A., Valladares L., Mondaca M., Laurido C., and Soto-Moyano R. Melatonin-induced inhibition of spinal cord synaptic potentiation in rats is MT2 receptor-dependent. Neurosci Lett 360 (2004) 41-44
17. Onal S.A., Inalkac S., Kutlu S., and Kelestimur H. Intrathecal melatonin increases the mechanical nociceptive threshold in the rat. Agri 16 (2004) 35-40
18. Pandi-Perumal S.R., Trakht I., Srinivasan V., Spence D.W., Maestroni G.J., Zisapel N., and Cardinali D.P. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol 85 (2008) 335-353
19. Pang S.F., Wan Q., and Brown G.M. Melatonin receptors in the spinal cord. Biol Signals 6 (1997) 272-283
20. Park H.T., Kim Y.J., Yoon S., Kim J.B., and Kim J.J. Distributional characteristics of the mRNA for retinoid Z receptor β (RZRβ), a putative nuclear melatonin receptor, in the rat brain and spinal cord. Brain Res 747 (1997) 332-337
21. Reiter R.J., Acuna-Castroviejo D., and Tan D.X. Melatonin therapy in fibromyalgia. Curr Pain Headache Rep 11 (2007) 339-342
22. Reiter R.J., Calvo J.R., Karbownik M., Qi W., and Tan D.X. Melatonin and its relation to the immune system and inflammation. Ann NY Acad Sci 917 (2000) 376-386
23. Rodriguez M.I., Escames G., Lopez L.C., Lopez A., Garcia J.A., Ortiz F., and Acuna-Castroviejo D. Chronic melatonin treatment reduces the age-dependent inflammatory process in senescence-accelerated mice. J Pineal Res 42 (2007) 272-279
24. Saha L., Malhotra S., Rana S., Bhasin D., and Pandhi P. A preliminary study of melatonin in irritable bowel syndrome. J Clin Gastroenterol 41 (2007) 29-32
25. Sengupta J.N., Medda B.K., and Shaker R. Effect of GABA(B) receptor agonist on distension-sensitive pelvic nerve afferent fibers innervating rat colon. Am J Physiol Gastrointest Liver Physiol 283 (2002) G1343-G1351
26. Shavali S., Ho B., Govitrapong P., Sawlom S., Ajjimaporn A., Klongpanichapak S., and Ebadi M. Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of beta-endorphin an endogenous opioid. Brain Res Bull 64 (2005) 471-479
27. Vogler B., Rapoport A.M., Tepper S.J., Sheftell F., and Bigal M.E. Role of melatonin in the pathophysiology of migraine: implications for treatment. CNS Drugs 20 (2006) 343-350
28. Yu C.X., Wu G.C., Xu S.F., and Chen C.H. Effect of melatonin on release of beta-endorphin, norepinephrine and 5-hydroxytryptamine in rat brain. Yao Xue Xue Bao 36 (2001) 5-9
29. Yu C.X., Zhu B., Xu S.F., Cao X.D., and Wu G.C. The analgesic effects of peripheral and central administration of melatonin in rats. Eur J Pharmacol 403 (2000) 49-53
30. Yu C.X., Zhu C.B., Xu S.F., Cao X.D., and Wu G.C. Selective MT(2) melatonin receptor antagonist blocks melatonin-induced antinociception in rats. Neurosci Lett 282 (2000) 161-164